Medicare Reimbursement Announced For Third Dose Of COVID-19 Vaccine For Immunocompromised Individuals
The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations for both the Pfizer-BioNTech and the Moderna COVID-19 vaccines to allow for the use of an additional dose in certain immunocompromised individuals, especially solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise on August 12, 2021.
Rethinking Outsourced Medical Coding in a Pandemic: Benefits, Best Practices, and Considerations
Hospital Inpatient Prospective Payment System & Long-Term Care Hospital Prospective Payment System For Fiscal Year 2022
The Centers for Medicare & Medicaid Services (CMS) has issued the final rule for fiscal year (FY) 2022 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Prospective Payment System (PPS). The rule revises the Medicare IPPS for operating and capital-related costs of acute care hospitals as well as for certain hospitals and hospital units excluded from the IPPS and updates the payment policies and the annual payment rates for inpatient hospital services provided by LTCHs under the LTCH PPS.
Inpatient Psychiatric Facility Prospective Payment System Final Rule For Fiscal Year 2022
The Centers for Medicare & Medicaid Services (CMS) has issued a final rule that updates Medicare payment policies and rates for the Inpatient Psychiatric Facility (IPF) Prospective Payment System (PPS) for Fiscal Year (FY) 2022 and finalizes changes to the IPF Quality Reporting Program (QRP).